As of Sep 20
| +0.007 / +8.43%|
The 1 analysts offering 12-month price forecasts for INSYS Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +1,011.11% increase from the last price of 0.09.
The current consensus among 1 polled investment analysts is to Hold stock in INSYS Therapeutics Inc. This rating has held steady since June, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.